Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.

Abstract

To evaluate the pharmacokinetic and pharmacodynamic characteristics of YH1885, a novel proton pump inhibitor, a single-blind, randomized, placebo-controlled, dose-rising, parallel-group study was conducted in 46 healthy volunteers. The volunteers were randomly allocated to single dose groups of 60 mg, 100 mg, 150 mg, 200 mg, and 300 mg (6 subjects per dose… (More)

Topics

Cite this paper

@article{Yu2004PharmacokineticAP, title={Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.}, author={Kyung-Sang Yu and Kyun-Seop Bae and Ji-Hong Shon and Joo Youn Cho and So-Young Yi and Jae-yong Chung and Hyeong-Seok Lim and In-Jin Jang and Sang-Goo Shin and Keun-Seog Song and Byoung-Seok Moon}, journal={Journal of clinical pharmacology}, year={2004}, volume={44 1}, pages={73-82} }